Luca Lazzari
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Stain normalization matters: impact on feature relevance and classifier performance in mCRC therapy response prediction.
Journal: Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference
Published: December 03, 2025
AI-Driven Pathomics for Predicting Chemotherapy Response in Metastatic Colorectal Cancer: A Transfer Learning Approach with Attention-Based Multiple Instance Learning.
Journal: Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference
Published: December 03, 2025
Consistency of Radiological Staging in Resectable Mismatch-Repair Proficient Colon Cancer: An Interobserver Agreement Study.
Journal: Clinical colorectal cancer
Published: October 17, 2025
Heterogeneity and evolution of DNA mutation rates in microsatellite stable colorectal cancer.
Journal: Science translational medicine
Published: May 21, 2025
Total neoadjuvant therapy followed by non-operative management or surgery in stage II-III rectal cancer (NO-CUT): a multicentre, single-arm, phase 2 trial.
Journal: The Lancet. Oncology
Published: May 15, 2025
A Comparative Study of Methyl-BEAMing and Droplet Digital PCR for MGMT Gene Promoter Hypermethylation Detection.
Journal: Diagnostics (Basel, Switzerland)
Published: September 11, 2024
Clinical utility and future perspectives of liquid biopsy in colorectal cancer.
Journal: Communications medicine
Published: May 10, 2024
Prediction of homologous recombination deficiency identifies colorectal tumors sensitive to PARP inhibition.
Journal: NPJ precision oncology
Published: March 04, 2024
Delta-Radiomics Predicts Response to First-Line Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients with Liver Metastases.
Journal: Cancers
Published: December 14, 2021
Temozolomide Treatment Alters Mismatch Repair and Boosts Mutational Burden in Tumor and Blood of Colorectal Cancer Patients.
Journal: Cancer discovery
Published: November 01, 2021
Last Updated: 09/26/2026